Olivier Decaux

6.9k total citations
78 papers, 1.8k citations indexed

About

Olivier Decaux is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Olivier Decaux has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hematology, 32 papers in Molecular Biology and 23 papers in Oncology. Recurrent topics in Olivier Decaux's work include Multiple Myeloma Research and Treatments (54 papers), Cancer Treatment and Pharmacology (12 papers) and Protein Degradation and Inhibitors (12 papers). Olivier Decaux is often cited by papers focused on Multiple Myeloma Research and Treatments (54 papers), Cancer Treatment and Pharmacology (12 papers) and Protein Degradation and Inhibitors (12 papers). Olivier Decaux collaborates with scholars based in France, United States and Belgium. Olivier Decaux's co-authors include Philippe Moreau, Hervé Avet‐Loiseau, Stéphane Minvielle, Florence Magrangeas, P. Jégo, Régis Bataille, Michel Attal, S. Jouneau, L. Campion and B. Grosbois and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Olivier Decaux

72 papers receiving 1.8k citations

Peers

Countries citing papers authored by Olivier Decaux

Since Specialization

Citations

This map shows the geographic impact of Olivier Decaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Decaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Decaux more than expected).

Fields of papers citing papers by Olivier Decaux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Decaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Decaux. The network helps show where Olivier Decaux may publish in the future.

Co-authorship network of co-authors of Olivier Decaux

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Decaux. A scholar is included among the top collaborators of Olivier Decaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Decaux. Olivier Decaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Retreatment With Anti-CD38-Based Combinations in Multiple Myeloma in Real-Life: Results From the Emmy Cohort Study 2025 ·Clinical Lymphoma Myeloma & Leukemia ·Alexis Talbot, Cyrille Hulin, Aurore Perrot, (unknown), (unknown), Mohamad Mohty, (unknown), Lionel Karlin, Morten Salomo, Laure Vincent, Abderrazak El Yamani, (unknown), (unknown), Thomas Chalopin, Daniel Ré, Adrienne de Labarthe, Olivier Fitoussi, (unknown), Ronan Garlantézec, Olivier Decaux	1
2	Real‐life effectiveness of carfilzomib in patients with relapsed multiple myeloma receiving treatment in the context of early access: The CARMYN study 2023 ·SHILAP Revista de lepidopterología ·(unknown), Xavier Leleu, Nathalie Texier, (unknown), Cyrille Touzeau, (unknown), (unknown), (unknown), Ronan Le Calloch, (unknown), Driss Chaoui, (unknown), (unknown), Riad Benramdane, (unknown), (unknown), (unknown), Olivier Decaux, Aurore Perrot	2
3	Signatures of Life Detected in Images of Rocks Using Neural Network Analysis Demonstrate New Potential for Searching for Biosignatures on the Surface of Mars 2023 ·Astrobiology ·Dov Corenblit, Olivier Decaux, Sébastien Delmotte, (unknown), (unknown), Marie‐Françoise André, José Darrozes, Neil S. Davies, Frédéric Julien, Thierry Otto, Guillaume Ramillien, Erwan Roussel, Johannes Steiger, Heather Viles	4
4	Venous thromboembolism prophylaxis and multiple myeloma patients in real-life: Results of a large survey and clinical guidance recommendations from the IFM group 2023 ·Thrombosis Research ·Laurent Frenzel, Olivier Decaux, Margaret Macro, (unknown), Salomon Manier, Cyrille Touzeau, Xavier Leleu, Corinne Frère, Thomas Lecompte, Aurore Perrot, Hervé Avet‐Loiseau, Philippe Moreau, Émilie Chalayer	13
5	PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma 2022 ·Blood ·(unknown), Gersende Caron, Fabrice Chatonnet, Stéphane Manenti, (unknown), (unknown), Céline Delaloy, Giulia Bertolin, Roselyne Viel, (unknown), (unknown), (unknown), Olivier Decaux, Karin Tarte, Laurent Delpy, Jérôme Moreaux, Thierry Fest	9
6	Four-Year Interim Analysis of Miroir, a French Multicenter, Non-Interventional Study of Pomalidomide in Relapsed/Refractory Multiple Myeloma 2019 ·Blood ·Olivier Decaux, Margaret Macro, Sophie Gourgou, Florence Lachenal, (unknown), Bertrand Arnulf, Denis Caillot, Anne‐Marie Stoppa, Laure Vincent, Arnaud Jaccard, Philippe Moreau, Aurore Perrot, Mohamad Mohty, Lionel Karlin, Cécile Fohrer, Jean‐Richard Eveillard, Jean Fontan, Xavier Leleu, Cyrille Hulin, Sylvain Choquet	0
7	Prognostic value of involved/uninvolved free light chain ratio determined by Freelite and N Latex FLC assays for identification of high-risk smoldering myeloma patients 2019 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), (unknown), Chloé Rousseau, Martine Escoffre, (unknown), Claude Bendavid, Stéphane Minvielle, Hervé Avet‐Loiseau, Olivier Decaux, Caroline Moreau	8
8	Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study 2018 ·PLoS ONE ·Nicolas Belhomme, S. Jouneau, Guillaume Bouzillé, Olivier Decaux, Mathieu Léderlin, Stéphanie Guillot, Antoinette Perlat, Patrick Jégo	20
9	Plasmacytoma-like post-kidney-transplant lymphoproliferative disorder confined to renal allograft and urinary tract: A case report 2018 ·Néphrologie & Thérapeutique ·(unknown), Joseph Rivalan, Francisco Llamas, (unknown), Olivier Decaux, Cécile Vigneau	2
10	Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review 2016 ·Leukemia Research ·Éric Grignano, A. Mékinian, Thorsten Braun, É. Liozon, M. Hamidou, Olivier Decaux, Xavier Puéchal, Jean‐Emmanuel Kahn, Y. Schoindre, Julien Rossignol, Olivier Lortholary, Bertrand Lioger, Olivier Hermine, Sophie Park, Lionel Adès, François Montestruc, Laure Ricard, Claude Gardin, Pierre Fenaux, O. Fain	36
11	IFM (Intergroupe francophone du myélome) recommendations for uniform interpretation of serum and urine protein electrophoresis in multiple myeloma diagnosis and follow-up 2016 ·Annales de biologie clinique ·Thomas Dejoie, Daniela Lakomy, Hélène Caillon, Brigitte Pegourié, Olivier Decaux	5
12	Inflammatory Arthritis in Patients With Myelodysplastic Syndromes 2013 ·Medicine ·A. Mékinian, Thorsten Braun, Olivier Decaux, Géraldine Falgarone, Éric Toussirot, Loïc Raffray, (unknown), Bruno Gombert, B. de Wazières, (unknown), Jean-Marc Ziza, David Launay, Guillaume Denis, S. Madaule, Christian Rose, Éric Grignano, Pierre Fenaux, O. Fain	45
13	Final Analysis of MELISSE, a Large Multicentric Observational Study to Determine Risk Factors of Venous Thromboembolism in Patients with Multiple Myeloma Treated with Immunomodulator Drugs 2011 ·Blood ·Xavier Leleu, (unknown), Philippe Rodon, Cyrille Hulin, Charles Dauriac, (unknown), Olivier Decaux, (unknown), (unknown), Laurent Voillat, Borhane Slama, Ahmad Al Jijakli, (unknown), Régis Costello, (unknown), (unknown), Jean Paul Fermand, Philippe Moreau	1
14	Translocation t(14;16) and multiple myeloma: is it really an independent prognostic factor? 2010 ·Blood ·Hervé Avet‐Loiseau, Florent Malard, L. Campion, Florence Magrangeas, Catherine Sebban, Bruno Lioure, Olivier Decaux, Thierry Lamy, Laurence Legros, Jean‐Gabriel Fuzibet, Mauricette Michallet, Bernadette Corront, Pascal Lenain, Cyrille Hulin, Claire Mathiot, Michel Attal, Thierry Façon, Jean‐Luc Harousseau, Stéphane Minvielle, Philippe Moreau, (unknown)	92
15	Wegener’s Granulomatosis Strictly and Persistently Localized to One Organ Is Rare: Assessment of 16 Patients from the French Vasculitis Study Group Database 2010 ·The Journal of Rheumatology ·Christian Pagnoux, (unknown), François Lifermann, Olivier Decaux, Michel Pavic, A. Bérezné, (unknown), N. Méaux-Ruault, Boris Bienvenu, J Cabane, Loı̈c Guillevin	23
16	Efficacy of Melphalan and Prednisone Plus Thalidomide in Patients Older Than 75 Years With Newly Diagnosed Multiple Myeloma: IFM 01/01 Trial 2009 ·Journal of Clinical Oncology ·Cyrille Hulin, Thierry Façon, Philippe Rodon, Brigitte Pegourié, Lotfi Benboubker, Chantal Doyen, Mamoun Dib, Gaëlle Guillerm, Bruno César Corrêa Salles, Jean‐Paul Eschard, Pascal Lenain, Philippe Casassus, I Azaïs, Olivier Decaux, Laurent Garderet, Claire Mathiot, Jean Fontan, Ingrid Lafon, J.-M. Virion, Philippe Moreau	266
17	Prediction of Survival in Multiple Myeloma Based on Gene Expression Profiles Reveals Cell Cycle and Chromosomal Instability Signatures in High-Risk Patients and Hyperdiploid Signatures in Low-Risk Patients: A Study of the Intergroupe Francophone du Myélome 2008 ·Journal of Clinical Oncology ·Olivier Decaux, Laurence Lodé, Florence Magrangeas, Catherine Guérin‐Charbonnel, Wilfried Gouraud, Pascal Jézéquel, Michel Attal, Jean‐Luc Harousseau, Philippe Moreau, Régis Bataille, L. Campion, Hervé Avet‐Loiseau, Stéphane Minvielle	269
18	Une ulcération anale inhabituelle 2007 ·Annales de Pathologie ·Anne‐Sophie de Lajarte‐Thirouard, Olivier Decaux, Laurent Siproudhis, Bruno Turlin	2
19	Suivi évolutif des gammapathies monoclonales de signification indéterminée 2006 ·La Presse Médicale ·Olivier Decaux, Marc Cuggia, A. Ruelland, C. Cazalets, (unknown), P. Jégo, B. Grosbois	5
20	Les carences en fer chez l’homme 2005 ·Bulletin de l Académie Nationale de Médecine ·B. Grosbois, Olivier Decaux, (unknown), C. Cazalets, P. Jégo	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact